Serine/threonine phosphorylation of the nonstructural protein 5 (NS5) is a conserved feature of flaviviruses, but the kinase(s) responsible and function(s) remain unknown. Mass spectrometry was used to compare the phosphorylation sites of the NS5 proteins of yellow fever virus (YFV) and dengue virus (DENV), two flaviviruses transmitted by mosquitoes. Seven DENV phosphopeptides were identified, but only one conserved phosphoacceptor site (threonine 449 in DENV) was identified in both viruses. This site is predicted to be a protein kinase G (PKG) recognition site and is a strictly conserved serine/threonine phosphoacceptor site in mosquito-borne flaviviruses. In contrast, in tick-borne flaviviruses, this residue is typically a histidine. A DENV replicon engineered to have the tick-specific histidine residue at this position is replication defective. We show that DENV NS5 purified from Escherichia coli is a substrate for PKG in vitro and facilitates the autophosphorylation of PKG as seen with cellular substrates. Phosphorylation in vitro by PKG also occurs at threonine 449. Activators and inhibitors of PKG modulate DENV replication in cell culture but not replication of the tick-borne langat virus. Collectively, these data argue that PKG mediates a conserved serine/threonine phosphorylation event specifically for flaviviruses spread by mosquitoes.
The flavivirus genus contains many medically important species, including dengue virus (DENV), yellow fever virus (YFV), West Nile virus (WNV), and tick-borne encephalitis virus (TBEV). More than 2 billion people are at risk of infection by DENV alone, leading to an estimated 50 million cases annually, which may increase further as the range of the mosquito vector expands with urbanization (24) . While disease from mosquito-borne flaviviruses is particularly common, there are other flaviviral human pathogens that exist with transmission cycles that do not involve mosquitoes. Tick-borne transmission is the other well-described route, but non-arthropodborne routes also exist (for example, bats). It is likely that each transmission route has genetic adaptations that facilitate that route, but such changes are not yet understood (7) .
Serine/threonine phosphorylation is a conserved feature across all three genera of the family Flaviviridae, including the genus flavivirus (the others genera being pestivirus and hepacivirus). Among the features of Flaviviridae, the most-studied examples are the multiple phosphorylations of nonstructural protein 5A (NS5A) of hepatitis C virus, which exists in both basal (termed p56) and hyperphosphorylated (termed p58) states mediated by multiple kinases that both are necessary for and limit replication (14, 18, 23) . Phosphorylation of NS5B, the RNA-dependent RNA polymerase (RdRP), has also been shown to affect replicon activity (10) . In the genus flavivirus, several mosquito-borne viruses (DENV, WNV, and YFV) and at least one tick-borne encephalitis virus are known to have phosphorylated forms of nonstructural protein NS5 (2, 9, 11, 13, 19) . In the genus flavivirus, NS5 is central to viral replication, as it possesses both RdRP and methyltransferase activities. DENV phosphorylation of NS5 correlates with the loss of NS5 interactions with the viral helicase NS3. A hyperphosphorylated form of NS5 was found to localize to the nucleus, away from the cytoplasmic sites of viral replication (6, 9) . A nuclear localization sequence is present in DENV NS5 and is phosphorylated in vitro by host CKII, but the relationship between phosphorylation and nuclear localization has yet to be fully elucidated (17) . Multiple different serine/threonine phosphorylation events likely occur in the flaviviral life cycle, potentially affecting various functions of NS5 (2) , but the role of these events and identity of the kinase(s) responsible are largely unknown.
In this report, we used mass spectrometry to identify serine/ threonine phosphorylation sites in DENV. A single phosphoacceptor site, previously identified in YFV, is conserved specifically in the mosquito-borne flaviviruses but not the tickborne flaviviruses. Furthermore, in vitro studies reveal that this site is phosphorylated by a cyclic-nucleotide-dependent kinase, protein kinase G (PKG), and a phosphoacceptor threonine/ serine is required for replication. Taken together, these data implicate the PKG pathway in flaviviral replication for the first time and suggest a host cell pathway that could be targeted by antiviral therapy.
vector pET30a by using ligation-independent cloning. The N-terminally Histagged constructs for full-length DENV-2 NS5 were transformed into Escherichia coli expression strain BL21-Codon Plus (DE3)-RIL cells (Stratagene). Largescale cultures (2 liters) for protein purification were grown in LB (supplemented with kanamycin and chloramphenicol), at 37°C, until the culture reached an optical density at 600 nm (OD 600 ) of 0.5. Protein expression was induced with IPTG (isopropyl-␤-D-thiogalactopyranoside) at a final concentration of 0.4 mM. The induced culture was then grown for 6 h at 25°C. Cells were harvested by centrifugation at 6,000 ϫ g for 10 min at 4°C and resuspended in lysis buffer containing 20 mM Na 2 PO 4 , pH 7.0, 0.5 M NaCl, 50 mM L-arginine, 50 mM L-glutamic acid, 10 mM MgSO 4 , 5 mM imidazole, 5 mM ␤-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, and 0.01 mg/ml (each) DNase I and RNase A. The cell suspension was lysed by sonication on ice, and the lysate was centrifuged at 25,000 ϫ g for 30 min at 4°C. The supernatant was filtered through a 0.45-m filter and subjected to immobilized metal affinity chromatography using a HisTrap HP column (GE Healthcare). The protein was eluted with 20 mM Na 2 PO 4 buffer, pH 7.0, containing 0.5 M NaCl and 300 mM imidazole. Proteincontaining fractions were then pooled, dialyzed overnight against 50 mM Tris buffer, pH 8.0, with 500 mM NaCl, 5 mM ␤-mercaptoethanol, and 5% glycerol, and concentrated. The concentrated protein was applied onto a Superdex 200 gel filtration column preequilibrated with the dialysis buffer. Fractions containing the full-length NS5 were pooled, and the protein was concentrated using a Vivaspin 30-kDa-molecular-mass-cutoff centrifugal concentrator (Vivascience). The purified protein was tested for in vitro RdRP activity as described in reference 21, with and without cyclic GMP (cGMP).
DENV-2 NS5 mutagenesis, RNA transcription, transfection, and replication analysis. A DENV-2 replicon cDNA (K. Combs, R. Perera, J. Smit, and R. J. Kuhn, unpublished results) was used to introduce mutations at position T449 of NS5. The replicon construct consisted of the DENV-2 genomic cDNA in which the genes encoding structural proteins were replaced by a Renilla luciferase reporter gene. Mutations T449S, T449H, and T449E were introduced into the DENV replicon cDNA by standard overlap PCR mutagenesis procedures (8) . RNA transcripts of DENV-2 replicon were generated by in vitro transcription using T7 RNA polymerase (Amersham Biosciences) from DNA templates linearized by digestion with XbaI restriction enzyme in the presence of the m 7 G(5Ј)ppp(5Ј)G cap analog (NEB). HEK293T cells in a 24-well plate were transfected with 0.8 g of purified RNA per well by using the Lipofectamine reagent (Invitrogen) according to manufacturer's instructions. A control replicon construct with NS5 catalytic aspartate residue deletions was transfected in parallel as a negative control. At 3, 6, 12, 24, 48, 72, 96 , and 120 h posttransfection, the medium was removed and cells were washed with phosphate-buffered saline and lysed with 100 l of 1ϫ Renilla lysis buffer from the Renilla Luciferase Assay System (Promega, Madison, WI). The lysates were stored at Ϫ80°C. Prior to the assay, frozen extracts were thawed and then homogenized by briefly being subjected to a vortex. Luciferase activity was initiated by the addition of 10 l of cytoplasmic extracts to 50 l of Renilla luciferase substrate. Luciferase activity was detected using a Turner Designs TD20/20 luminometer and measured in relative light units.
YFV and DENV NS5-IRES-GFP constructs. The full length of either YFV NS5 (vaccine strain; GenBank accession no. X03700) or DENV NS5 (dengue type 2; GenBank accession no. M19197) was amplified from a DNA template by PCR with primers that introduce an XhoI site, Kozak sequences, an in-frame start codon (ATG) 5Ј to the NS5 sequence, and a PacI site, as well as six-His codons in frame and a stop codon at the 3Ј end. The ϳ2.8-kb PCR product was digested and cloned into the pIRES/GFP bicistronic mammalian expression vector (provided by Kouacou V. Konan, Penn State University, University Park, PA) in XhoI-PacI sites and sequenced. YFV NS5 T450A was generated by an overlap PCR strategy (8) with an introduction of threonine-to-alanine mutations in overlapping primer pairs. Second-step PCR products were directly cloned into a wild-type YFV NS5 six-His-tagged internal ribosome entry site (IRES)-green fluorescent protein (GFP) construct by replacing the Bsu36I-AvrII fragment and sequenced.
Expression and purification of YFV NS5 and DENV NS5 proteins in HEK293T cells. GFP in the IRES vector was used as a transfection/expression marker. Transfection of the empty vector was performed in parallel in each case as a negative control. Fifteen micrograms of YFV NS5 DNA, DENV NS5 DNA, or empty vector DNA was transfected with a cocktail of TransIT-LT1 (MirusBio, Madison, WI) into a T-75 flask containing 70 to 80% confluent HEK293T cells and incubated for 48 h in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1ϫ penicillin-streptomycin solution (Invitrogen, La Jolla, CA) at 37°C in a 5% CO 2 incubator. The procedures for transfection, expression, and purification of the six-His-tagged protein were described previously (2) .
Mass spectrometry sample preparation, sample loading, and analysis. SixHis-tagged, purified, and NS5-immunoprecipitated proteins (from experimental, empty vector, and mock-infected controls) from HEK293T cells were electrophoresed in 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels. The gels were stained with GelCode Blue stain (Thermo Fisher Scientific, MA). An ϳ100-kDa band was excised from the gel. In-gel digestion was performed with trypsin (Trypsin Gold, mass spectrometry grade; Promega, Madison, WI), dephosphorylated with calf intestinal alkaline phosphatase (CIAP) if necessary, purified with OMIX C 18 Zip-Tip column (Varian, Harbor City, CA), and run in both matrix-assisted laser desorption ionization (MALDI)-tandem time of flight (TOF) (Applied Biosystems, Foster City, CA) and Finnigan LTQ linear ion trap (Thermo Fisher Scientific, MA) mass spectrophotometers for liquid chromatography-tandem mass spectrometry LC-MS-MS as described elsewhere (2) . For MALDI-TOF analysis, the mass spectra were collected from m/z values of 700 to 4,000, and preliminary analysis was performed with GPS Explorer software (Applied Biosystems, Foster City, CA). After performing a Mascot database (Matrix Science, London, United Kingdom) search and data comparison before and after CIAP treatment (for the wild type only), detailed matching of mass with peptide identification was performed with MS-Digest tools (Web-based software in Protein Prospector, version 4.27.1). Electrospray ionization (ESI) mass spectrometry was performed for LC-MS-MS analysis. ESI precursor ion scan mass spectra were obtained using the Finnigan LTQ linear ion trap mass spectrometer equipped with a nanoelectrospray ion source. A Zorbax 300SB-C18 nanoflow high-performance liquid chromatography (HPLC) column (150 mm by 75 m; Agilent Technologies, Santa Clara, CA) was eluted with a linear gradient of water-acetonitrile in the presence of 0.1% formic acid at a flow rate of 0.2 l/min. The remainder of the protocol was followed as described elsewhere (3), and full-scan spectra were recorded from m/z values of 200 to 2,000 followed by the recording of MS-MS spectra in Xcalibur software (Thermo Fisher Scientific, MA). MS-MS spectra of detected phosphopeptides were searched against the FASTA database by using the Sequest search program within BioWorks Rev3.3 software (Thermo Fisher Scientific, MA).
In vitro phosphorylation of DENV NS5 by PKG. In vitro protein phosphorylation assays were performed by incubating 1 g of bacterially expressed fulllength six-His-tagged DENV NS5 protein with 5 Ci of [␥- Seven peptides were found to have a mass 80 Da greater than calculated when all residues were assumed to be unphosphorylated, and each lost 80 Da upon phosphatase treatment. The sequence of the peptide detailed in this study is given, and the threonine phosphorylated is in boldface.
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the supplied PKG stock solution was diluted in 8 l of PKG dilution buffer containing 10 mM HEPES (pH 7.5), 1 mM EDTA, 6 mM dithiothreitol, 1 mg/ml bovine serum albumin, and 1x Halt protease inhibitor cocktail (Thermo Fisher Scientific, Waltham, MA). The reaction mixtures were incubated at 30°C for 15 min and terminated by adding Laemmli sample buffer in the reaction mixture, boiled for 3 min, and run in 10% SDS-PAGE. After the gel was dried, incorporated 32 P was detected by exposure of the gel to Kodak BioMax XAR film (Perkin Elmer, Waltham, MA) for 12 h at Ϫ80°C. The same gel was rehydrated in water for 1 h and stained with Coomassie blue to serve as a protein loading control.
Mass spectrometric analysis of in vitro-phosphorylated DENV NS5 by PKG.
For mass spectrometry analysis of the in vitro kinase assay, the same protocol as described above was followed except that 0.2 mM nonradioactive ATP was used instead of [␥-32 P]ATP and the reaction mixture was incubated for 1 h at 30°C. After a staining with GelCode Blue solution (Thermo Fisher Scientific, Waltham, MA), the band of interest was excised from the gel, alkylated, in-gel digested with trypsin, further purified with OMIX C 18 Zip-Tip column, and run in both MALDI-TOF and ESI analyses as described previously (2) . Cytotoxicity assays. Cytotoxicity of the compounds that alter PKG activity was measured spectrophotometrically by monitoring the reduction of a tetrazolium salt to a formazan dye by mitochondrial dehydrogenase in living cells in the presence or absence of the compound. HEK293T cells were grown in DMEM, supplemented with 10% FBS in a 96-well plate at 37°C, and overlaid with culture media containing serial dilutions of the PKG inhibitor or activator (concentrations of 0.25 M to 5 M) or dimethyl sulfoxide (0.1% to 1%). Untreated cells served as positive controls. Cells were then incubated at 37°C in 5% CO 2 for ϳ48 h. The medium on cells was then replaced with 100 l of WST-1 substrate from the Quick Cell proliferation kit (Biovision Inc., CA), diluted in DMEM and 2.5% FBS. Cells were incubated at 37°C for an additional 2 h. Plates were then removed, and the OD 450 values were measured using a 96-well plate reader (Molecular Devices, Sunnyvale, CA). The OD 450 values for cells treated with the compounds that alter PKG were compared to those obtained for cells treated with the dimethyl sulfoxide-treated or untreated controls to determine relative cytotoxicity.
Bioinformatics logo analysis. After alignment of 689 different full-length genomes from mosquito-borne flaviviruses and 26 tick-borne flaviviruses available through the Viral Bioinformatic Resource Center (www.biovirus.org), the logo analysis was performed using a Web-based program called WebLogo (5).
RESULTS
A conserved threonine residue is a phosphorylated site in YFV and DENV NS5. In a previous study, NS5 of YFV was purified from mammalian cells, and seven tryptic phosphopeptides were identified via MALDI; all seven had a mass 80 Da greater than predicted (2). All fragments lost 80 Da when exposed to CIAP, and these fragments represented at least six unique serine/threonine phosphorylation sites (2) (one site was represented twice, once by an incomplete tryptic digest). Here, we pursued a similar strategy and transfected HEK293T cells with a genetic construct that expresses six-His-tagged DENV NS5. The NS5 protein was purified using metal affinity chromatography, and the protein was excised from an SDS-PAGE gel. The products of both phosphatase-treated and untreated tryptic digests were compared. For both the YFV NS5 and the DENV NS5, peptides that cover over half of the total polypeptide (either at the calculated mass or 80 Da greater than the calculated mass) could be detected as ionized by the mass spectrometer. Therefore, many but not all of the conserved potential phosphorylated sites for both proteins could be compared. As in YFV, seven peptides whose mass was 80 Da greater than predicted and could be shifted to the predicted mass by phosphatase treatment were identified, but six of the sites were not identified previously (Fig. 1) . Only one homologous peptide with an identical phosphorylation site in both YFV NS5 and DENV NS5 could be identified. Figure 2A shows the m/z of the YFV peptide C 448 RTCVYNMMGKR 459 , 1,636.9243, as well as the putative phosphorylated version of this peptide, with an m/z of 1,716.9217. Figure 2B shows that the higher-m/z peptide was lost after this preparation was treated with CIAP. Similar data were obtained for a smaller peptide, T 450 CVYNMMGK 458 , which also suggested that T450 was phosphorylated (data not shown). When a T450A mutant YFV NS5 construct was engineered, transfected into cells, and purified, neither the 1,636.9243 nor the 1,716.9217 m/z was detected (data not shown). Definitive evidence for phosphorylation at that particular site was provided by LC-MS-MS ionization of the mass shown in Fig. 2C . The homologous phosphorylated peptide C 447 ET p CVYNMMGKREK 460 (where the subscript "p" indicates that the T is phosphorylated) could also be identified when DENV NS5 was expressed in HEK293T cells (Fig. 3A) . Treatment with CIAP led to the loss of this 5 . MALDI-TOF analysis of in vitro-phosphorylated DENV NS5 generated by trypsin digestion and purified from E. coli. The six-Histagged, purified full length of DENV NS5 (amino acid coordinate number G1-L901) was incubated in the presence of bovine lung PKG I␣, cGMP, and ATP in an in vitro kinase reaction. An ϳ100-kDa band of DENV NS5 was excised from SDS-PAGE gel, and after in-gel tryptic digestion, the phosphopeptides were detected by MALDI-TOF analysis. A single asterisk indicates the monoisotopic peak of the phosphorylated peptide corresponding to amino acids N 440 LHLEGKCET p CVYNMMGK 557 , with an m/z of 2,291.9620. The phosphopeptide mass was calculated with an addition of 79.9 for one phosphate in the T 449 position in the peptide sequences.
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peak and detection of an m/z consistent with the unphosphorylated form (Fig. 3B ). In the experiment involving YFV (Fig.  2) , both phosphorylated and unphosphorylated versions of NS5 were detected in the sample not treated with CIAP, but in the DENV experiment, the unphosphorylated form was found only after CIAP treatment. Again, LC-MS-MS analysis of the phosphorylated peak revealed that this m/z corresponds to N 440 LHLEGKCET p CVYNMMGK 457 (Fig. 3C) . The threonine in this peptide corresponds to amino acid 449 instead of 450, as in the case of YFV NS5, due to a one-amino-acid insertion in the YFV methyltransferase domain relative to DENV NS5, yet the surrounding cysteines at both sites provide strong evidence that these two amino acids are structurally homologous.
DENV threonine 449 is phosphorylated by PKG in vitro. The threonine residue identified above as a phosphorylated site in both DENV and YFV NS5 proteins is also predicted to be phosphorylated by PKG via the neural net bioinformatics program (4) . PKG kinases (isoforms I␣, I␤, and II) are present in both mammals and insects. The PKGs regulate and are regulated by cGMP levels in the cell (20) . Purified PKG I␣ (bovine lung) was therefore used in vitro to phosphorylate recombinant DENV NS5 purified from E. coli (unphosphorylated). [␥-32 P]ATP, PKG I␣, and DENV NS5 were incubated for 15 min at 30°C in the presence and absence of cGMP. In the presence of cGMP, DENV NS5 became phosphorylated (Fig. 4, lane 1, upper band) . It is noteworthy that some degree of autophosphorylation of PKG was detected (Fig. 4, lane 1,  lower band) . This autophosphorylation is frequently modulated by cellular substrates of PKG and occurs at multiple sites (22) . It occurred in the absence of DENV NS5 substrate (Fig.  4, lane 2) and was enhanced by the presence of cGMP (compare the lower bands in lane 2 and lane 3). In the absence of cGMP, DENV NS5 was still phosphorylated by PKG I␣, and again, autophosphorylation of PKG occurred (Fig. 4, lane 6 ). More autophosphorylation of PKG in the absence of cGMP occurred when DENV NS5 was present (Fig. 4 , compare the lower bands in lane 6 and lane 2 in the top panel), whereas when cGMP was present, the opposite occurred (compare lower bands of lane 3 and lane 1). This suggested a complex interplay between the exogenous substrate (DENV NS5) and the PKG autophosphorylation sites that may be altered by cGMP, an allosteric activator of PKG. PKG I␤ (human) and PKG II (rat) also were able to phosphorylate DENV NS5 in vitro (data not shown). In vitro kinase reactions of DENV NS5 with PKG were then analyzed by mass spectrometry to determine if the same threonine was phosphorylated both in cells (shown in Fig. 1 and 2 ) and in vitro. A phosphorylation reaction involving PKG I␣, cGMP, and NS5 (Fig. 4, lane 1) was performed with nonradioactive ATP. The NS5 band was excised from an SDS-PAGE gel, digested with trypsin, and analyzed by MALDI-TOF analysis. A peak consistent with the m/z of the phosphorylated peptide was found (Fig. 5) . Taken together, these data argue that the conserved CXTC motif (with X indicating R or E) is accessible both in vitro and in cells to be phosphorylated and can be phosphorylated by any of the members of the PKG family.
DENV NS5 residue 449 phosphorylation is detectable in infected cells. HEK293T cells were infected with DENV at a multiplicity of infection of 10, and cell lysates were harvested at 48 h. A polyclonal antibody specific to NS5 was used to immunoprecipitate NS5, which was then analyzed by SDS-PAGE. Three faint bands (Fig. 6A ) not present in the immunoprecipitation lysate from mock-infected cells but detected by Western blotting with anti-NS5 antibody (Fig. 6B ) were excised and trypsinized before being subjected to MALDI-TOF analysis (Applied Biosystems, Foster City, CA) ( Fig. 6C and D) . MS-MS revealed that residue 449 of DENV NS5 was phosphorylated (Fig. 6E) .
The CXTC phosphoacceptor site is conserved specifically in the mosquito-borne lineage but not the tick-borne lineage of flaviviruses. Due to the conserved nature of the CXTC motif between YFV and DENV, we examined this motif throughout the genus. Using the Viral Bioinformatics Resource Center website (www.biovirus.org), we examined Ͼ700 full flaviviral genomes. Among viruses transmitted by mosquitoes, 689 different full genomes were available (several different isolates of DENV-1 to DENV-4, YFV, WNV, and Japanese encephalitis virus, among others), and for all of these, either a serine or threonine phosphoacceptor site was present in the protein (Fig. 7A) . On the other hand, from the 26 available full genomes from viruses known to be transmitted by ticks, neither serine nor threonine was present at the relevant position; rather, a CXHC or CXQC motif was observed (Fig. 7B) .
Replacement of Thr with His polymorphism from tick-borne flaviviruses rendered the DENV replicon nonfunctional. To determine the importance of Thr449, the DENV subgenomic replicon was engineered to replace the threonine in the CXTC motif with a serine, histidine, or a glutamic acid. The positively charged mutant histidine that naturally occurs in tick-borne viruses rendered the DENV replicon nonfunctional. Replacement of threonine with glutamic acid (a negatively charged residue which may mimic the effect of a nonreversible phosphorylation event) also significantly impaired DENV replicon replication (Fig. 8) . However, the efficiency of replication from the DENV replicon containing the serine mutant was almost as high as that from the threonine-containing wild type. 
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Modulation of PKG levels alters DENV replication but not LGTV replication. We next examined if cell-permeable small molecules that either activate or inhibit PKG activity directly also modulate DENV replication. HEK293T cells were treated with various concentrations of a cell-permeable activator of PKG (8-Br-PET-cGMP, Na) (Fig. 9A) or a cell-permeable PKG inhibitor (Rp-8-pCPT-cGMPS, TEA) (Fig. 9B) before infection with DENV, and the yield of virus was measured by a focus-forming assay. Chemical activation and inhibition of PKG caused opposite and statistically significant changes to the DENV yield in the culture supernatant. Chemical activation of PKG activity resulted in viral production fourfold greater than the production without activation (P value, 0.0006). This is in contrast to the almost 10-fold inhibition of viral production when PKG was chemically inhibited relative to viral production without inhibition (P value, 0.00005). Neither drug exerted significant or observable cytotoxicity at these concentrations, as measured by an MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] assay. No change in viral titers occurred when tick-borne-virus (LGTV)-infected HEK293T cells were treated with the same concentrations of the PKG activator (P value of 0.84 for the comparison of 0 M to 5 M; Fig. 9C ) and the PKG inhibitor (P value, 0.96; Fig. 9D ). We also utilized an siRNA approach to silence PKG in HEK293T cells to investigate if this resulted in a similar viral inhibition that was specific to DENV over LGTV. siRNA inhibition decreased both PKG I␣ levels, according to Western blot analysis, and total PKG activity ( Fig. 10A and B) at both 48 and 96 h. Cells were infected 48 h after either mock transfection or transfection of PKG I␣/␤ siRNA or scrambled siRNA, and the viral yields were measured 48 h after infection. DENV replication in the PKG-silenced cells was ϳ2 logs lower than that in the scrambled RNA control cells (P value, Ͻ0.00001; Fig. 10C ), while LGTV was not affected (Fig. 10D) . These results suggest that PKG activity modulates mosquitoborne flaviviral replication in human cells but not tick-borne flaviviral replication.
DISCUSSION
In this report, we mapped a potential serine/threonine flaviviral phosphorylation site that is conserved in two different mosquito-borne viruses, DENV and YFV. Furthermore, we show that this specific site of NS5 can be phosphorylated by cGMP-dependent PKG in vitro. While the first suggestion that this phosphorylation site was recognized by PKG came from a neural net bioinformatics program, it is noteworthy that this viral site differs from the well-described RKRKXST motif of the canonical PKG substrates (20) . Since the PKG signaling pathway regulates a variety of physiological processes in many different cell types, it is likely that not all the recognition sites are known. Three enzymes mediate cGMP-dependent kinase activity in mammalian cells. They are produced from two genes, cGKI (which produces PKG I␣ and PKG I␤) and cGKII (which produces PKG II). The enzymes from these genes differ in their tissue distributions, subcellular localizations, and substrates. At least in vitro, all three are able to phosphorylate DENV NS5, even though in vivo they have different substrates and regulate a diverse range of physiological functions, including learning, circadian rhythm, phototaxis, vascular tone, kidney function, platelet aggregation, and intestinal secretion (20) . The pharmacologic data presented here suggest that modulation of PKG activity alters DENV replication. The phosphoacceptor motif described above is conserved in all four serotypes of DENV, YFV, WNV, and Japanese encephalitis virus, as well all other flaviviruses known to be transmitted by mosquitoes, but not the tick-borne flaviviruses (Fig. 7) . A threonine-to-serine variation is common at position 449 in DENV isolates, particularly in DENV-3 and DENV-4. Based on the crystal structure of DENV-3 NS5 (Fig. 11) , the residue 449 site is solvent exposed and is likely accessible to a kinase. Mosquito-borne flaviviruses have diverged in their evolution to have a serine or threonine phosphoacceptor site at this position, unlike other flaviviruses. Whether there are additional properties besides phosphorylation that make a threonine/ serine requirement is unclear at present. When purified fulllength DENV NS5 was phosphorylated in vitro with PKG I␣ and the polymerase activity was compared to nonphosphorylated protein, no enhancement or inhibition of activity was observed (data not shown). Our evidence suggests that a transient phosphorylation at residue 449 on a threonine is tolerated by DENV replication, but placement of a nonreversible negative charge, such as the glutamic acid at residue 449, is detrimental to genome replication. A histidine is also not tolerated in replication, even though it is the observed residue in tickborne flaviviruses.
Currently, we have evidence only that cGMP-dependent pathways alter DENV replication in mammalian cells, and there are no published data on PKG activity in mosquitoes. PKG activity is known to exist in drosophilae and honey bees. It is noteworthy, though, that PKG activity has been linked to behavior in a wide variety of organisms, including mammals and insects (19) . For drosophilae (15) and honey bees (1), both genetic and pharmacologic data have linked PKG activity to insect foraging behavior. While the idea is speculative, there may be evolutionary advantages for viruses transmitted by mosquitoes to encode PKG substrates that have little to do with viral replication in cell culture. It is unclear if the phosphoacceptor is conserved for virus replication reasons or other attributes required for the virus to be evolutionarily successful.
In conclusion, DENV, like YFV, has a number of usable phosphoacceptor sites consistent with a hyperphosphorylated form in viral infection (2, 9) . Surprisingly, only one of these sites was found in both YFV and DENV. Other sites could be phosphorylated in both because we were not able to detect peptides covering the entire protein for either viral protein.
While phosphorylation of serines and threonines of NS5 is known to occur in both mosquito-borne (9, 11) and tick-borne (13) flaviviruses, this residue is specifically conserved for flaviviruses transmitted by mosquitoes. This site is phosphorylated by cGMP-activated PKG in a cell-free assay. Replacement of threonine with the tick-specific residue is detrimental to DENV replication. Modulations of the cGMP pathway, such as either activation or inhibition of PKG, alter DENV repli- FIG. 11 . Structure of DENV-3 polymerase domain, with T449 highlighted. The DENV-3 RNA polymerase (residues 273 to 896) structure was used to map the DENV-2 threonine 449. The corresponding residue in DENV-3 is a serine which has been changed to a threonine (red) in this representation. The finger, palm, and thumb subdomains of the RdRP are colored gray, purple, and cyan, respectively. The nuclear localization sequence regions are shown in yellow, and the conserved aspartate residues involved in the catalytic reaction (motif C) are shown as stick representations in orange, while the site of catalysis is indicated with an orange asterisk. An enlarged view of the region around T449 shows that the residue is located on a loop with a solvent-exposed side chain. This location indicates that the threonine side chain could be accessible to the cellular kinase during the phosphorylation reaction, and significant movement between the subdomains during polymerization could either expose or make the residue inaccessible for phosphorylation. T449 is far removed from the site of polymerization, making its direct contribution to the enzymatic reaction unlikely.
